ST JUDE MEDICAL INC | 36,122 Euro | -0,379 -1,04 % | |
| WKN: 864096 ISIN: US7908491035 Ticker-Symbol: JUD | Frankfurt | 21.05.13 | 08:09 Uhr |
Branche GesundheitswesenAktienmarkt S&P 500 |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 17.05. | St Jude Medical: The Winning Streak Continues | - | SmarTrend | |
| 17.05. | St. Jude Medical meldet Europazulassung für 3D-Gefäßrekonstruktionstechnologie zur Unterstützung von Stent-Implantationen | 47 | Business Wire | |
| Zukunftswegweisendes System ermöglicht 360-Grad-Panoramadarstellung der Arterien in 3D St. Jude Medical, Inc. (NYSE:STJ), ein weltweit tätiges Medizintechnik-Unternehmen, gab heute... Mehr lesen zu: St. Jude Medical meldet Europazulassung für 3D-Gefäßrekonstruktionstechnologie zur Unterstützung von Stent-Implantationen | ||||
| 16.05. | St. Jude Announces CE Mark Approval For Ilumien Optis PCI Optimization System | 34 | AFX News | |
| WASHINGTON (dpa-AFX) - St. Jude Medical, Inc. (STJ), a medical devices
company, Thursday announced CE mark approval of its Ilumien Optis PCI
Optimization System, a new technology designed... Mehr lesen zu: St. Jude Announces CE Mark Approval For Ilumien Optis PCI Optimization System | ||||
| 16.05. | St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement | 39 | Business Wire | |
| Next-generation system provides a real-time 360-degree panoramic view of the arteries in 3-D St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced... Mehr lesen zu: St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement | ||||
| 15.05. | St Jude Medical: 52-Week High Recently Eclipsed | - | SmarTrend | |
| 14.05. | Recent 52-Week High Exceeded in Shares of St Jude Medical | - | SmarTrend | |
| 14.05. | St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System | 2 | Benzinga.com | |
| 13.05. | Shares of St Jude Medical Rise Above Previous 52-Week High | - | SmarTrend | |
| 12.05. | Shares of St Jude Medical Rank the Lowest in Terms of EBITDA Growth in the Health Care Equipment Industry | - | SmarTrend | |
| 10.05. | St Jude Medical Set to Possibly Pullback After Yesterday's Rally of 2.51% | - | SmarTrend | |
| 08.05. | St. Jude Medical Gets CE Mark Approval Of Ellipse And SJM Assura ICDs And CRT-Ds | 58 | AFX News | |
| WASHINGTON (dpa-AFX) - Medical devices company St. Jude Medical Inc. (STJ)
Wednesday announced CE Mark approval of its next-generation Ellipse and SJM
Assura portfolio of implantable cardioverter... Mehr lesen zu: St. Jude Medical Gets CE Mark Approval Of Ellipse And SJM Assura ICDs And CRT-Ds | ||||
| 06.05. | SmarTrend Watching for Potential Pullback in Shares of St Jude Medical After 2.06% Gain | - | SmarTrend | |
| 06.05. | St Jude Medical Set to Possibly Pullback After Yesterday's Rally of 2.06% | - | SmarTrend | |
| 06.05. | St. Jude Medical Gets Too Much Praise | 2 | The Street | |
| 03.05. | ST JUDE MEDICAL INC - 8-K, Current Report | - | SEC Filings | |
| 02.05. | St. Jude Medical schüttet 25 Cents Dividende aus | 2 | MyDividends.de | |
| 02.05. | St. Jude Medical meldet CE-Zulassung und Verkaufsstart des ersten quadripolaren CRT-Herzschrittmachers | 60 | Business Wire | |
| Allure Quadra setzt neue Maßstäbe bei Herzschrittmachern für die kardiale Resynchronisations-Therapie St. Jude Medical, Inc. (NYSE:STJ), ein weltweit tätiges Medizintechnik-Unternehmen... Mehr lesen zu: St. Jude Medical meldet CE-Zulassung und Verkaufsstart des ersten quadripolaren CRT-Herzschrittmachers | ||||
| 30.04. | St. Jude Medical Gets CE Mark Approval For Allure Quadra CRT-Pacemaker | 49 | AFX News | |
| WASHINGTON (dpa-AFX) - St. Jude Medical Inc. (STJ) Tuesday said its Allure
Quadra Cardiac Resynchronization Therapy Pacemaker or CRT-P received CE Mark
approval and subsequently is being... Mehr lesen zu: St. Jude Medical Gets CE Mark Approval For Allure Quadra CRT-Pacemaker | ||||
| 30.04. | St. Jude Medical (STJ) Receives CE Mark for, Launched Allure Quadra CRT-P | - | StreetInsider.com | |
| 30.04. | St. Jude Medical Announces CE Mark, Launch of First Quadripolar CRT Pacemaker | - | Benzinga.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| BOSTON SCIENTIFIC | 7,215 | +3,74 % | Boston Scientific Presents Clinical Data at Digestive Disease Week |
| MEDTRONIC | 38,541 | -1,06 % | Credit Suisse stuft Medtronic von Outperform auf Neutral ab |
| RHOEN-KLINIKUM | 16,895 | +1,62 % | Im Fokus: Rhön-Klinikum AG |
| WELLPOINT | 59,53 | -0,72 % | New WellPoint CEO Consolidates Health Insurer's Business Units |
| ECKERT & ZIEGLER | 25,67 | -0,58 % | XETR DIVIDEND INFORMATION - 20.05.2013 - 1 |
